Kuzari Group
2
4M
2
0.17
1
- Stages of investment
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the New York. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, Ironwood Capital, Enhanced Capital Partners. In the next rounds fund is usually obtained by Yale University, Horizon Technology Finance, EJ Funds.
The common things for fund are deals in the range of 1 - 5 millions dollars. The top amount of exits for fund were in 2000. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2012.
Among the various public portfolio startups of the fund, we may underline Precipio Diagnostics, New Haven Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Health Care. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.17
- Investments by industry
- Biotechnology (2)
- Therapeutics (1)
- Pharmaceutical (1)
- Health Care (1)
- Health Diagnostics (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| New Haven Pharmaceuticals | 29 Oct 2012 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 6M | United States, Connecticut |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.